Skip to content
healthcare.dev

TZIELD

NDC 73650-316, teplizumab-mzwv, injection, from Provention Bio, Inc..

Product NDC
73650-316
Status
Listed
Labeler
Provention Bio, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761183
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73650-316 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEPLIZUMAB1 mg/mL

Pharmacologic classes

CD3-directed Antibody Interactions [MoA]; CD3-directed Antibody [EPC]

Package NDCNDC-11Package
73650-316-01736500316011 VIAL, SINGLE-DOSE in 1 CARTON (73650-316-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e8a39a5f-139c-4510-9777-71cbb00138fa
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=73650-316

Use it

Look up 73650-316 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73650-316 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73650-316. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.